Owkin Announces Multi-year Collaboration With Sanofi To Co-Develop Next-generation Biopharma Agents, To Be Backed By Five-year License For K Pro AI Scientist, Deal Terms Were Not Disclosed

Benzinga Newsdesk www.benzinga.com Neutral 60.3%

Neg 0% Neu 60.3% Pos 0%

Comments

No comments yet. Be the first!